Calcineurin phosphatase activity: activation by glucocorticoids and role of intracellular calcium

Transplantation. 2004 Jan 27;77(2):259-67. doi: 10.1097/01.TP.0000099267.05131.11.

Abstract

Background: Glucocorticoids stimulate release of intracellular calcium in peripheral lymphocytes, but their effects on calcineurin phosphatase activity are unknown.

Methods: Calcineurin phosphatase activity was measured in permeabilized Jurkat T cells using a specific orthophosphate substrate. Changes in intracellular calcium were measured by FURA-2 fluorescence. Inositol triphosphate levels were measured by radioimmunoassay. Transfection with luciferase reporter plasmids linked to glucocorticoid response elements were used to evaluate glucocorticoid receptor function in Jurkat T cells.

Results: Dexamethasone significantly (P<0.004) increased calcineurin activity within 15 sec, peaking at 10 min (P<0.001) and returning to basal levels by 180 min. Inhibition of DNA transcription with actinomycin D failed to block calcineurin activation, but co-incubation with RU-486 completely blocked enzyme stimulation. To determine whether Jurkat T cells express active glucocorticoid receptors, cells were transfected with a luciferase reporter plasmid linked to a glucocorticoid response element (GRE). Jurkat T cells incubated with dexamethasone (10 microM) for 24 hr failed to stimulate luciferase activity, whereas cells co-transfected with a transcriptionally active glucocorticoid receptor resulted in a doubling of luciferase activity. Dexamethasone rapidly increases intracellular inositol triphosphate (IP3) and intracellular calcium within 15 sec. Cells incubated with U-73122 (a nonspecific phospholipase C [PLC] antagonist) completely blocked dexamethasone-induced activation of calcineurin, whereas U-73343 failed to block enzyme activation. Dexamethasone-induced activation of calcineurin activity stimulates dephosphorylation of the proapoptotic protein BAD and augments apoptosis through a calcineurin-dependent pathway.

Conclusion: Dexamethasone rapidly increases calcineurin activity through a transcription-independent mechanism involving activation of phospholipase C and the release of IP3-dependent calcium stores.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Annexin A5 / metabolism
  • Calcium / physiology*
  • Dactinomycin / pharmacology
  • Dexamethasone / pharmacology*
  • Enzyme Activation / drug effects
  • Enzyme Inhibitors / pharmacology
  • Estrenes / pharmacology
  • Gene Expression Regulation, Enzymologic / drug effects
  • Glucocorticoids / pharmacology*
  • Humans
  • Inositol 1,4,5-Trisphosphate / metabolism
  • Jurkat Cells
  • Kinetics
  • Mifepristone / pharmacology
  • Phosphoric Monoester Hydrolases / drug effects
  • Phosphoric Monoester Hydrolases / genetics
  • Phosphoric Monoester Hydrolases / metabolism*
  • Pyrrolidinones / pharmacology
  • T-Lymphocytes / enzymology*
  • Tetradecanoylphorbol Acetate / pharmacology
  • Transcription, Genetic / drug effects
  • Type C Phospholipases / antagonists & inhibitors
  • Type C Phospholipases / metabolism

Substances

  • Annexin A5
  • Enzyme Inhibitors
  • Estrenes
  • Glucocorticoids
  • Pyrrolidinones
  • 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione
  • Dactinomycin
  • Mifepristone
  • Dexamethasone
  • Inositol 1,4,5-Trisphosphate
  • calcineurin phosphatase
  • Phosphoric Monoester Hydrolases
  • Type C Phospholipases
  • Tetradecanoylphorbol Acetate
  • Calcium